SCHEMBL23018232

SCHEMBL23018232

OCC1C[C@H](O)CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2897023 1.00
SCHEMBL2904129 1.00
SCHEMBL15909334 1.00
SCHEMBL23564432 1.00
SCHEMBL1569653 1.00
Hydrochloric Acid SCHEMBL2925918 0.98 AGL (0.41)
Hydrochloric Acid SCHEMBL2925474 0.98 AGL (0.41)
Hydrochloric Acid SCHEMBL2925479 0.98 AGL (0.41)
Hydrochloric Acid SCHEMBL2925920 0.98 AGL (0.41)
Hydrochloric Acid SCHEMBL2925477 0.98 AGL (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3782655-A1 A METHOD FOR THE TREATMENT OF POMPE DISEASE USING 1-DEOXYNOJIRIMYCIN AND DERIVATIVES Amicus Therapeutics, Inc. (US) 2021-02-24 EP disclosed